Skip to content

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here. Hide this message

Laboratory Medicine

Test Directory / DPD mutation analysis for 5-fluorouracil (5-FU) toxicity

DPD mutation analysis for 5-fluorouracil (5-FU) toxicity

EDTA

TestDPD mutation analysis for 5-fluorouracil (5-FU) toxicity
Common AbbreviationsDPD-5FU
ProfileNA
Tube typeEDTA
Clinical IndicationPolymorphic variants in the DPYD gene are associated with severe, sometimes fatal, toxicity to fluoropyrimidine therapy.
Specimen TypeBlood
Sample typeWhole blood
Minimum Volume3mL
Special PrecautionsNo special requirements
Stability5 days at 2 - 8°C
Turnaround TimeContact Referral Laboratory
LaboratoryPurine Research Laboratory, St Thomas' Hospital, London, SE1 7EH. 020 7188 1266
Reference IntervalInterpretation provided on report
Limitations
NotesPlease complete ViaPath request form and send with request http://www.viapath.co.uk/sites/default/files/upload/DPD-5FU%20REQUEST%20FORM.XLSX
A receptionist at an information stand reading some paperwork

Your Visit

Logo on blue with swoosh

Fundraising

Chinese Poland

View all languages >

Invitation to attend the Trust’s Annual Members Meeting

Trust members and the general public are invited to find out more about their local hospitals by attending the Trust’s virtual Annual Members Meeting (AMM), incorporating the Annual General Meeting (AGM), on Tuesday 26 October 2021, between 11:00am-12:30pm.